Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kenya Tamada"'
Autor:
Natsuki Yokoue, Takehiko Abe, Hideaki Abe, Akira Sato, Shingo Nakajima, Sei-ichi Tanuma, Kenya Tamada, Fumiaki Uchiumi, Haruki Tachibana, Takahiro Oyama, Natsumi Ogawa, Takanori Kamiya, Atsushi Yoshimori, Takehiko Yokomizo, Miwa Okazawa, Hiroaki Yamazaki
Publikováno v:
Archives of biochemistry and biophysics. 711
Because of the critical roles of Toll-like receptors (TLRs) and receptor for advanced glycation end-products (RAGE) in the pathophysiology of various acute and chronic inflammatory diseases, continuous efforts have been made to discover novel therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3af2891cfb1dccd5117384a59f3b6f
https://pubmed.ncbi.nlm.nih.gov/34517011
https://pubmed.ncbi.nlm.nih.gov/34517011
Autor:
Haruki Tachibana, Miwa Okazawa, Takanori Kamiya, Hideaki Abe, Natsuki Yokoue, Kazumi Yoshizawa, Sei-ichi Tanuma, Takehiko Yokomizo, Atsushi Yoshimori, Shingo Nakajima, Shigeaki Inoue, Kenya Tamada, Akira Sato, Fumiaki Uchiumi, Takehiko Abe, Natsumi Ogawa, Takahiro Oyama
Publikováno v:
Biochemical and biophysical research communications. 533(4)
We previously identified papaverine as an inhibitor of receptor for advanced glycation end-products (RAGE) and showed its suppressive effect on high mobility group box 1 (HMGB1)-mediated responses to inflammation. Here, we found trimebutine to be a 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c483ea2ef360de6194cdc50198716c56
https://pubmed.ncbi.nlm.nih.gov/33041002
https://pubmed.ncbi.nlm.nih.gov/33041002
Autor:
Atsushi Yoshimori, Mana Inada, Takahiro Oyama, Nobuo Watanabe, Yusuke Suzuki, Takehiko Abe, Hiroyuki Shibasaki, Ryoko Takasawa, Kenya Tamada, Shingo Nakajima, Hideaki Abe, Sei-ichi Tanuma, Akira Sato, Natsumi Ogawa, Takehiko Yokomizo, Shigeaki Inoue
Publikováno v:
Biochemical and biophysical research communications. 511(3)
The interaction of high mobility group box 1 (HMGB1), which is secreted from immune and dying cells during cellular infection and injury, and receptor for advanced glycation end-products (RAGE) appears to be critical for acute and chronic inflammator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::488a8a9eb30f2f440031826161a1be26
https://pubmed.ncbi.nlm.nih.gov/30826057
https://pubmed.ncbi.nlm.nih.gov/30826057